[Effects on growth, tolerability and biochemical parameters of two different human milk fortifiers in very low birth-weight newborns]
- PMID: 15529811
[Effects on growth, tolerability and biochemical parameters of two different human milk fortifiers in very low birth-weight newborns]
Abstract
Objectives: The aim of the study was to compare a group of very low birth-weight infants feeded with a preterm formula with two other groups feeded with human milk and two different fortifiers.
Methods: 30 preterm newborns with birth-weight < 1.500 g, admitted to the Neonatal Intensive Care Unit (NICU) of Department of Neonatology of Catholic University of Rome were randomized for three different feeding groups: total enteral nutrition with HM fortified with Enfamil Human Milk fortifier or with Eoprotin, compared to a group feeded with Similac 24 preterm formula. Statistical analysis was performed using the two-way analysis of variance (ANOVA).
Results: During the study and at the end we found a growth rate for weight, cranial circumference and lenght similar to the fetal standard growth rate in the third trimester of pregnancy in all the three groups. Fortified HM was well tolerated. No pathologic value of the biochemical parameters studied was found. Higher level of serum phosphorus in spite of significantly lower intakes of phosphorus occurred in fortified HM feeded neonates, as if there was a better availability of this nutrient in HM.
Conclusions: This study demonstrates the role of fortified HM as a good alternative to the preterm formula.
Similar articles
-
Growth, efficacy, and safety of feeding an iron-fortified human milk fortifier.Pediatrics. 2004 Dec;114(6):e699-706. doi: 10.1542/peds.2004-0911. Epub 2004 Nov 15. Pediatrics. 2004. PMID: 15545616 Clinical Trial.
-
Adjustable fortification of human milk fed to preterm infants: does it make a difference?J Perinatol. 2006 Oct;26(10):614-21. doi: 10.1038/sj.jp.7211571. Epub 2006 Aug 3. J Perinatol. 2006. PMID: 16885989 Clinical Trial.
-
Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age.Pediatrics. 2006 Jul;118(1):e115-23. doi: 10.1542/peds.2005-2382. Pediatrics. 2006. PMID: 16818526
-
Enteral nutrition support of the preterm infant in the neonatal intensive care unit.Nutr Clin Pract. 2009 Jun-Jul;24(3):363-76. doi: 10.1177/0884533609335310. Nutr Clin Pract. 2009. PMID: 19483066 Review.
-
Nutrition of preterm infants after hospital discharge.J Pediatr Gastroenterol Nutr. 2007 Dec;45 Suppl 3:S195-203. doi: 10.1097/01.mpg.0000302972.13739.64. J Pediatr Gastroenterol Nutr. 2007. PMID: 18185092 Review.
Cited by
-
Infant formulas containing hydrolysed protein for prevention of allergic disease and food allergy.Cochrane Database Syst Rev. 2017 Mar 15;3(3):CD003664. doi: 10.1002/14651858.CD003664.pub4. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2017 May 25;5:CD003664. doi: 10.1002/14651858.CD003664.pub5. PMID: 28293923 Free PMC article. Updated.
-
WITHDRAWN: Infant formulas containing hydrolysed protein for prevention of allergic disease and food allergy.Cochrane Database Syst Rev. 2017 May 25;5(5):CD003664. doi: 10.1002/14651858.CD003664.pub5. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2018 Oct 19;10:CD003664. doi: 10.1002/14651858.CD003664.pub6. PMID: 28542713 Free PMC article. Updated.
-
Infant formulas containing hydrolysed protein for prevention of allergic disease.Cochrane Database Syst Rev. 2018 Oct 19;10(10):CD003664. doi: 10.1002/14651858.CD003664.pub6. Cochrane Database Syst Rev. 2018. PMID: 30338526 Free PMC article.